aInstitute of Clinical Pharmacology, Hannover Medical School, Hannover
bDepartment of Medicine, University of Leipzig, Leipzig
cClinic for Endocrinology, Diabetes and Nutrition, Experimental & Clinical Research Center, Charité University Medicine, Berlin
dInstitute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany
eLaboratory of Physiologic Studies, NIAAA, Bethesda, Maryland, USA
Correspondence to Stefan Engeli, MD, Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. Tel: +49 511 532 2796; fax: +49 511 532 2750; e-mail: [email protected]
Abbreviations AEA, anandamide; CB1, cannabinoid type 1 receptor; FAAH, fatty acid amide hydrolase; OEA, oleoyl ethanolamide; OSA, obstructive sleep apnea; RDI, respiratory distress index; SaO2, arterial oxygen saturation; T90, time with SaO2 less than 90%
Received 4 August, 2011
Revised 16 July, 2012
Accepted 8 August, 2012
